The nation of Zimbabwe has turned down a major US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years due to the United States' demand for confidential information.
This rejection came to light after a internal memorandum from December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesman has since explained that the United States was demanding access to genetic material for scientific study and commercial purposes while was unwilling to share the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable process of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for continued talks to find a deal agreeable to all parties so the nation's vital HIV treatment initiative can be sustained.
Wider Context
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court blocked a related deal with the US after concerns were raised about the security of citizens' health data.
After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.
Based on reports, 16 African countries have to date agreed to similar agreements, representing more than $18.3bn in new funding.
Specifics of the Declined Deal
The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to provide its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any medical innovations – like new medicines or tests – that could result from that provided information," he stated.
"In essence, our nation would supply the basic resources for medical research with no assurance that the end products would be available to our population if a future pandemic emerge."
Sovereignty and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending systems previously set up through the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework created to deal with future pandemics.
"This framework is designed to guarantee that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome ongoing discussions with our US partners on how future co-operation might be structured in a way that respects the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that talks need to persist since much of the nation's Aids initiatives depended on international support.
"If technical issues arise, including those involving information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it added.
The situation underscores the continuing challenges between accepting crucial international aid and safeguarding a country's data in an increasingly interconnected world.